In the case of hyperinsulinemia, insulin continues to drive lipogenesis via the SREBP1 pathway in addition to failing to suppress gluconeogenesis, contributing to exacerbating hepatic steatosis [15]. The gene discussed is INS; the disease is fatty liver disease.